ETM Experimental and Therapeutic Medicine 1792-0981 1792-1015 D.A. Spandidos 10.3892/etm.2026.13244 ETM-32-3-13244 Retraction [Retracted] Dapagliflozin can alleviate renal fibrosis in rats with streptozotocin-induced type 2 diabetes mellitus XueSong LiYing-Xuan LuXiao-Xiao TangWei 092026 20072026 32 3 249 Copyright: © 2026 Xue et al. 2026 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Exp Ther Med 26:572, 2023; DOI: 10.3892/etm.2023.12271

Following the publication of the above paper, the authors requested that a corrigendum be published after they had identified that errors were made in assembling the western blot data in Figs. 4E and 5B. Upon performing an independent analysis of the data in this paper, however, it came to light that the vimentin blots in Fig. 4E and the Total-Smad3 blots in Fig. 5B were strikingly similar to data that had already appeared in other articles written by different authors at different research institutes published in the journals Cancer Medicine Reports and Inflammation respectively.

Given that the contentious data described above had already been published before this paper was submitted to Experimental and Therapeutic Medicine, the Editor has decided that this paper should be retracted from the Journal. After contacting the authors, they accepted the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.